http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-496013-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5bf3224236325d34b6c84558b906954
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-04
filingDate 1966-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70552cc6ba50458c660f27537ce1b4e0
publicationDate 1970-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CH-496013-A
titleOfInvention Process for the preparation of new substituted amines and their use
abstract Amines (I) and their acid salts- R1 = H, alkyl R2 = H, OH R3,4 = OH, opt. etherified, halogen, alkyl A = Th.CH2CHR5.CH2 or Th.CH2CH2, where Th = theobromine or theophylline and R5 = H or OH Z = A, H or alkyl; when H or alkyl, A = Th.CH2CHOH-CH2. nor-ephedrino-N-hydroxypropyltheophylline (II), nor-ephedrino-N-di-(hydroxypropyltheophylline), (beta-(beta'-phenyl-beta'-hydroxyethylamino)-hydroxypropyl) -theophylline, ephedrino-N-hydroxypropyltheophylline. The cpds. show marked sympathicomimetic action. Also cardiac and circulatory activity.
priorityDate 1965-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410712052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454062057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415006318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21889777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783

Total number of triples: 40.